SOMATROPIN

SOMATROPIN was reported 74878 times

SOMATROPIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DEVICE INFORMATION OUTPUT ISSUE 7077 0.9080
1 DEVICE CHEMICAL PROPERTY ISSUE 54 0.8060
2 AIR IN DEVICE ISSUE 31 0.7209
3 PATIENT-DEVICE INTERACTION ISSUE 34 0.6939
4 DEVICE CALIBRATION FAILURE 32 0.6038
5 DEVICE MECHANICAL ISSUE 8152 0.5940
6 DEVICE POWER SOURCE ISSUE 1635 0.5595
7 CRANIOPHARYNGIOMA 185 0.5572
8 EXPIRED DEVICE USED 1463 0.4408
9 DEVICE USER INTERFACE ISSUE 15 0.4167
10 INSULIN-LIKE GROWTH FACTOR DECREASED 216 0.4083
11 DEVICE PHYSICAL PROPERTY ISSUE 3050 0.3977
12 DRUG ADMINISTERED IN WRONG DEVICE 368 0.3759
13 DEVICE MATERIAL ISSUE 791 0.3758
14 EPIPHYSIOLYSIS 90 0.3614
15 GLIONEURONAL TUMOUR 19 0.3519
16 BLOOD GROWTH HORMONE DECREASED 70 0.3465
17 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 791 0.3329
18 PITUITARY TUMOUR RECURRENT 56 0.3218
19 POOR QUALITY DEVICE USED 3210 0.3196
20 DEVICE MATERIAL OPACIFICATION 14 0.3111
21 INSULIN-LIKE GROWTH FACTOR INCREASED 390 0.2733
22 SEPTO-OPTIC DYSPLASIA 18 0.2727
23 WRONG DEVICE USED 175 0.2668
24 DEVICE LEAKAGE 11126 0.2563
25 DRUG DOSE OMISSION BY DEVICE 19220 0.2452
26 DEVICE BREAKAGE 9710 0.2390
27 GERM CELL CANCER 31 0.2138
28 ADENOIDAL HYPERTROPHY 77 0.2037
29 INADVERTENT INJECTION AIR BUBBLE 24 0.1905
30 PRODUCT RECONSTITUTION QUALITY ISSUE 170 0.1899
31 BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED 55 0.1897
32 MEDULLOBLASTOMA RECURRENT 21 0.1858
33 OSTEOCHONDROMA 22 0.1849
34 MEDULLOBLASTOMA 25 0.1678
35 PRODUCT KNOWLEDGE DEFICIT 129 0.1650
36 HEPATOBLASTOMA 16 0.1649
37 DEVICE USE ISSUE 2834 0.1618
38 EPIPHYSES PREMATURE FUSION 49 0.1617
39 DEVICE ELECTRICAL FINDING 114 0.1610
40 BONE DENSITY INCREASED 59 0.1479
41 BLOOD GROWTH HORMONE ABNORMAL 18 0.1475
42 CEREBRAL SALT-WASTING SYNDROME 14 0.1414
43 GROWTH HORMONE DEFICIENCY 56 0.1411
44 GROWING PAINS 38 0.1402
45 GROWTH FAILURE 47 0.1366
46 PITUITARY CYST 15 0.1351
47 DEVICE DEFECTIVE 2335 0.1346
48 NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL INCREASED 34 0.1259
49 DEVICE DISPENSING ERROR 140 0.1185
50 ACROMEGALY 37 0.1167
51 INCORRECT DOSE ADMINISTERED BY DEVICE 2875 0.1096
52 LIQUID PRODUCT PHYSICAL ISSUE 792 0.1085
53 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5061 0.1082
54 GROWTH DISORDER 28 0.1037
55 GROWTH ACCELERATED 22 0.1019
56 DEVICE USE ERROR 3445 0.0990
57 PITUITARY TUMOUR BENIGN 159 0.0974
58 ALBUMIN GLOBULIN RATIO INCREASED 13 0.0949
59 DEVICE DELIVERY SYSTEM ISSUE 2532 0.0924
60 OSTEOCHONDROSIS 105 0.0904
61 GROWTH RETARDATION 251 0.0852
62 PITUITARY TUMOUR 127 0.0851
63 ASTROCYTOMA 32 0.0810
64 BLOOD FOLLICLE STIMULATING HORMONE DECREASED 14 0.0795
65 PATIENT-DEVICE INCOMPATIBILITY 54 0.0791
66 DEVICE USE CONFUSION 41 0.0784
67 DEVICE FAILURE 1178 0.0773
68 DEVICE CONNECTION ISSUE 149 0.0705
69 ADENOIDAL DISORDER 18 0.0692
70 CREUTZFELDT-JAKOB DISEASE 20 0.0692
71 PRECOCIOUS PUBERTY 39 0.0683
72 PRODUCT CONTAMINATION WITH BODY FLUID 14 0.0683
73 THYROXINE FREE DECREASED 38 0.0673
74 NEUROFIBROMATOSIS 14 0.0670
75 BLOOD GROWTH HORMONE INCREASED 37 0.0663
76 PRIMARY HYPOTHYROIDISM 14 0.0660
77 INJECTION SITE DISCHARGE 354 0.0658
78 DEVICE ISSUE 5869 0.0654
79 BLOOD FOLLICLE STIMULATING HORMONE INCREASED 25 0.0639
80 BONE DEVELOPMENT ABNORMAL 18 0.0632
81 DELAYED PUBERTY 16 0.0630
82 DEVICE OCCLUSION 863 0.0613
83 SYRINGOMYELIA 17 0.0612
84 HYPOTHALAMO-PITUITARY DISORDER 89 0.0611
85 NEOPLASM RECURRENCE 201 0.0592
86 HYPONATRAEMIC SEIZURE 14 0.0551
87 MALOCCLUSION 16 0.0548
88 DOSE CALCULATION ERROR 32 0.0546
89 BLOOD INSULIN INCREASED 30 0.0543
90 TONSILLAR DISORDER 61 0.0542
91 ADENOIDECTOMY 21 0.0541
92 ADRENOCORTICAL INSUFFICIENCY ACUTE 105 0.0538
93 PRODUCT SUBSTITUTION 21 0.0520
94 PRODUCT PRESCRIBING ERROR 1221 0.0512
95 PRODUCT COMMUNICATION ISSUE 444 0.0503
96 PRODUCT DEPOSIT 78 0.0500
97 THYROXINE INCREASED 35 0.0496
98 LACK OF ADMINISTRATION SITE ROTATION 14 0.0459
99 REACTION TO PRESERVATIVES 35 0.0430
100 SCOLIOSIS 260 0.0419
101 DEVICE OPERATIONAL ISSUE 180 0.0418
102 OSTEOSARCOMA 16 0.0416
103 HYPOPITUITARISM 69 0.0396
104 ARNOLD-CHIARI MALFORMATION 37 0.0388
105 TONSILLAR HYPERTROPHY 64 0.0380
106 CEREBRAL CYST 26 0.0378
107 PROTEIN-LOSING GASTROENTEROPATHY 18 0.0362
108 NEEDLE ISSUE 1054 0.0362
109 DEVICE MALFUNCTION 2429 0.0345
110 PRODUCT PREPARATION ISSUE 226 0.0344
111 THYROXINE FREE INCREASED 22 0.0344
112 BRAIN NEOPLASM 315 0.0343
113 EXPOSURE VIA EYE CONTACT 14 0.0333
114 THYROXINE DECREASED 20 0.0323
115 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1076 0.0318
116 GLIOMA 20 0.0311
117 EXPOSURE VIA SKIN CONTACT 798 0.0308
118 BLOOD CORTICOTROPHIN DECREASED 15 0.0307
119 DEVICE BATTERY ISSUE 20 0.0304
120 LACK OF INJECTION SITE ROTATION 53 0.0303
121 BENIGN INTRACRANIAL HYPERTENSION 37 0.0295
122 DEVICE LOOSENING 25 0.0289
123 OBSTRUCTIVE SLEEP APNOEA SYNDROME 42 0.0288
124 WRONG DOSE 69 0.0285
125 INTENTIONAL DEVICE MISUSE 124 0.0281
126 FEAR OF INJECTION 200 0.0280
127 PRODUCT CONTAMINATION PHYSICAL 71 0.0279
128 BLOOD CREATININE DECREASED 86 0.0274
129 DIABETES INSIPIDUS 66 0.0274
130 SNORING 102 0.0270
131 FOCAL NODULAR HYPERPLASIA 14 0.0269
132 IDIOPATHIC INTRACRANIAL HYPERTENSION 60 0.0267
133 HEPATIC ADENOMA 13 0.0251
134 INTRACRANIAL PRESSURE INCREASED 139 0.0249
135 BLOOD ALBUMIN INCREASED 22 0.0247
136 PAPILLOEDEMA 111 0.0246
137 PHAEOCHROMOCYTOMA 16 0.0243
138 BLOOD IMMUNOGLOBULIN A INCREASED 13 0.0241
139 MULTIPLE USE OF SINGLE-USE PRODUCT 132 0.0235
140 POOR QUALITY PRODUCT ADMINISTERED 247 0.0234
141 MEAN PLATELET VOLUME INCREASED 14 0.0232
142 KNEE DEFORMITY 34 0.0229
143 CORTISOL INCREASED 14 0.0224
144 DEVICE DIFFICULT TO USE 1473 0.0222
145 LIMB ASYMMETRY 17 0.0221
146 BLOOD CORTISOL DECREASED 14 0.0219
147 DEVELOPMENTAL HIP DYSPLASIA 18 0.0216
148 PRODUCT SOLUBILITY ABNORMAL 109 0.0216
149 ENDOCRINE DISORDER 27 0.0210
150 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 33 0.0206
151 SUSPECTED OFF LABEL USE 93 0.0206
152 BLOOD THYROID STIMULATING HORMONE DECREASED 93 0.0205
153 CORTISOL DECREASED 23 0.0201
154 HYPERTROPHIC CARDIOMYOPATHY 31 0.0200
155 CARBON DIOXIDE DECREASED 22 0.0191
156 INJECTION SITE DISCOMFORT 198 0.0188
157 HYPOGLYCAEMIC SEIZURE 17 0.0187
158 INTENTIONAL DEVICE USE ISSUE 16 0.0187
159 ANION GAP INCREASED 25 0.0187
160 INJECTION SITE EXTRAVASATION 224 0.0181
161 BLOOD ALKALINE PHOSPHATASE DECREASED 17 0.0179
162 INCORRECT DOSAGE ADMINISTERED 87 0.0178
163 BLOOD TESTOSTERONE INCREASED 38 0.0177
164 BLOOD UREA DECREASED 21 0.0169
165 LIMB DEFORMITY 26 0.0164
166 DRUG DELIVERY SYSTEM ISSUE 32 0.0162
167 DEVICE DEPOSIT ISSUE 33 0.0162
168 ADRENAL DISORDER 31 0.0161
169 HORMONE LEVEL ABNORMAL 78 0.0160
170 MEAN CELL HAEMOGLOBIN DECREASED 29 0.0158
171 PRODUCT CONTAMINATION 56 0.0157
172 GLIOBLASTOMA MULTIFORME 13 0.0154
173 HIGH DENSITY LIPOPROTEIN DECREASED 51 0.0153
174 DEVICE DEPLOYMENT ISSUE 195 0.0152
175 CRYPTORCHISM 17 0.0151
176 HAEMATOCRIT INCREASED 34 0.0149
177 INSULIN RESISTANCE 31 0.0149
178 FEBRILE CONVULSION 18 0.0148
179 HEPATIC NECROSIS 55 0.0146
180 SLEEP APNOEA SYNDROME 275 0.0144
181 PRODUCT EXPIRATION DATE ISSUE 20 0.0143
182 INJECTION SITE HAEMORRHAGE 1138 0.0142
183 BLOOD SODIUM INCREASED 38 0.0141
184 INJECTION SITE BRUISING 1119 0.0140
185 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 23 0.0138
186 PRODUCT LEAKAGE 77 0.0137
187 DENGUE FEVER 31 0.0135
188 BLOOD CHLORIDE INCREASED 23 0.0133
189 AUTISM SPECTRUM DISORDER 73 0.0132
190 DEVICE SAFETY FEATURE ISSUE 13 0.0132
191 PRODUCT ODOUR ABNORMAL 138 0.0132
192 MEAN CELL VOLUME DECREASED 20 0.0130
193 INCORRECT DOSE ADMINISTERED 2831 0.0124
194 INJECTION SITE PAIN 3770 0.0123
195 STRABISMUS 36 0.0122
196 ADMINISTRATION SITE PAIN 14 0.0121
197 SPINAL DEFORMITY 20 0.0119
198 UNDERWEIGHT 23 0.0117
199 PRODUCT DOSE OMISSION 759 0.0116
200 INTERCEPTED PRODUCT SELECTION ERROR 15 0.0115
201 OTITIS MEDIA 38 0.0115
202 INJURY ASSOCIATED WITH DEVICE 232 0.0114
203 TONSILLECTOMY 19 0.0114
204 GLUCOSE TOLERANCE IMPAIRED 67 0.0113
205 LIPODYSTROPHY ACQUIRED 24 0.0113
206 TYPE 1 DIABETES MELLITUS 68 0.0113
207 PRODUCT AVAILABILITY ISSUE 257 0.0113
208 OFF LABEL USE OF DEVICE 15 0.0111
209 INJECTION SITE ATROPHY 18 0.0109
210 SKIN STRIAE 16 0.0107
211 ENURESIS 43 0.0106
212 APPENDIX DISORDER 15 0.0106
213 INTERCEPTED PRODUCT PRESCRIBING ERROR 14 0.0106
214 INJECTION SITE PARAESTHESIA 16 0.0104
215 VITAMIN D DECREASED 89 0.0104
216 HYPERPHAGIA 41 0.0103
217 HYPERTRICHOSIS 19 0.0102
218 POLYCYTHAEMIA 21 0.0102
219 TONSILLITIS 53 0.0101
220 RED BLOOD CELL COUNT INCREASED 28 0.0101
221 HYDROCEPHALUS 55 0.0101
222 PRODUCT STORAGE ERROR 875 0.0100
223 ACCIDENTAL EXPOSURE TO PRODUCT 1006 0.0098
224 RENAL TRANSPLANT 35 0.0097
225 SCREAMING 61 0.0096
226 GLIOBLASTOMA 16 0.0094
227 AORTIC VALVE DISEASE 15 0.0093
228 PRODUCT PREPARATION ERROR 190 0.0092
229 PAPILLARY THYROID CANCER 16 0.0092
230 INJECTION SITE INJURY 51 0.0092
231 INCORRECT DRUG ADMINISTRATION RATE 38 0.0089
232 CRANIOCEREBRAL INJURY 27 0.0089
233 RED CELL DISTRIBUTION WIDTH INCREASED 37 0.0089
234 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 163 0.0089
235 PRODUCT DISPENSING ISSUE 37 0.0086
236 SKIN ODOUR ABNORMAL 34 0.0086
237 NEOPLASM 99 0.0086
238 BLOOD PARATHYROID HORMONE INCREASED 25 0.0086
239 LYMPHOCYTE COUNT INCREASED 28 0.0086
240 PRODUCT LABEL CONFUSION 50 0.0086
241 EDUCATIONAL PROBLEM 14 0.0084
242 TYMPANIC MEMBRANE PERFORATION 14 0.0083
243 INJECTION SITE VESICLES 50 0.0083
244 PRODUCT SUPPLY ISSUE 58 0.0081
245 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 50 0.0081
246 DEVICE INFUSION ISSUE 20 0.0081
247 BLOOD THYROID STIMULATING HORMONE INCREASED 74 0.0080
248 UNDERDOSE 587 0.0080
249 PRODUCT DISPENSING ERROR 172 0.0079
250 BLOOD TESTOSTERONE DECREASED 54 0.0079
251 JUVENILE IDIOPATHIC ARTHRITIS 19 0.0078
252 INFECTIOUS MONONUCLEOSIS 17 0.0076
253 VENTRICULAR HYPERTROPHY 19 0.0076
254 BRAIN OPERATION 17 0.0074
255 WRONG PATIENT RECEIVED MEDICATION 20 0.0073
256 MELANOCYTIC NAEVUS 32 0.0073
257 PRODUCT PHYSICAL ISSUE 147 0.0073
258 TIBIA FRACTURE 34 0.0072
259 APNOEA 56 0.0072
260 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 123 0.0072
261 HAEMOGLOBIN INCREASED 32 0.0070
262 MEAN CELL VOLUME INCREASED 18 0.0070
263 VIITH NERVE PARALYSIS 24 0.0069
264 LIPOMA 18 0.0069
265 PRODUCT STORAGE ISSUE 26 0.0069
266 BLOOD PROLACTIN INCREASED 32 0.0068
267 HAIR GROWTH ABNORMAL 46 0.0066
268 MONOCYTE COUNT INCREASED 24 0.0066
269 ENERGY INCREASED 39 0.0066
270 ASTHMATIC CRISIS 24 0.0066
271 PRODUCT DOSE OMISSION ISSUE 1927 0.0065
272 HYPOPHYSITIS 13 0.0065
273 ELECTRIC SHOCK SENSATION 18 0.0064
274 RECURRENT CANCER 26 0.0064
275 PRODUCT USE COMPLAINT 100 0.0063
276 INCREASED APPETITE 121 0.0063
277 PRODUCT PHYSICAL CONSISTENCY ISSUE 35 0.0063
278 INJECTION SITE SCAR 18 0.0063
279 APPENDICITIS 59 0.0063
280 PRODUCT CONTAINER ISSUE 54 0.0063
281 BLOOD PHOSPHORUS INCREASED 17 0.0062
282 BLOOD CHLORIDE DECREASED 16 0.0062
283 LOW DENSITY LIPOPROTEIN INCREASED 48 0.0062
284 THYROID NEOPLASM 17 0.0062
285 CARPAL TUNNEL SYNDROME 86 0.0061
286 PRE-EXISTING CONDITION IMPROVED 38 0.0061
287 INJECTION SITE MASS 224 0.0061
288 POOR QUALITY DRUG ADMINISTERED 39 0.0060
289 INJECTION SITE DISCOLOURATION 75 0.0060
290 CRYING 218 0.0060
291 BREAST SWELLING 16 0.0059
292 BLOOD TRIGLYCERIDES INCREASED 105 0.0059
293 PRODUCT ADMINISTRATION ERROR 120 0.0059
294 HEPATIC ENCEPHALOPATHY 55 0.0059
295 GASTROENTERITIS 86 0.0059
296 MYOPIA 14 0.0059
297 VARICELLA 14 0.0059
298 PRODUCT COLOUR ISSUE 30 0.0058
299 NEPHROTIC SYNDROME 40 0.0058
300 MENOPAUSE 15 0.0058
301 BRAIN NEOPLASM MALIGNANT 26 0.0058
302 FAILURE TO THRIVE 30 0.0058
303 HYPERNATRAEMIA 28 0.0056
304 EPILEPSY 169 0.0055
305 ADRENAL INSUFFICIENCY 67 0.0055
306 BLOOD ALKALINE PHOSPHATASE INCREASED 137 0.0055
307 THERAPY CHANGE 54 0.0055
308 BRAIN INJURY 55 0.0055
309 DRUG DOSE OMISSION 902 0.0055
310 BEHAVIOUR DISORDER 29 0.0054
311 PRODUCT ADMINISTRATION INTERRUPTED 42 0.0053
312 VIRAL INFECTION 177 0.0053
313 ACUTE LYMPHOCYTIC LEUKAEMIA 15 0.0053
314 INTENTIONAL DOSE OMISSION 150 0.0053
315 SYRINGE ISSUE 92 0.0053
316 EAR DISORDER 24 0.0052
317 ACCIDENTAL OVERDOSE 191 0.0052
318 PRODUCT LABEL ISSUE 35 0.0052
319 CONCUSSION 39 0.0050
320 VITAMIN D DEFICIENCY 49 0.0050
321 MOOD ALTERED 137 0.0050
322 THYROID DISORDER 77 0.0050
323 MENINGIOMA 78 0.0050
324 HUMERUS FRACTURE 24 0.0050
325 ACCIDENT 59 0.0049
326 OESOPHAGEAL DISORDER 19 0.0049
327 BREAST ENLARGEMENT 16 0.0049
328 PRODUCT TEMPERATURE EXCURSION ISSUE 25 0.0049
329 GASTROENTERITIS VIRAL 87 0.0048
330 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 968 0.0048
331 TIC 26 0.0048
332 UPPER LIMB FRACTURE 93 0.0047
333 WOUND COMPLICATION 16 0.0047
334 GOITRE 19 0.0046
335 OBESITY 73 0.0046
336 POLYDIPSIA 18 0.0045
337 GLYCOSYLATED HAEMOGLOBIN INCREASED 114 0.0045
338 HAND FRACTURE 32 0.0045
339 ATTENTION DEFICIT HYPERACTIVITY DISORDER 19 0.0045
340 AUTOIMMUNE THYROIDITIS 17 0.0045
341 BLOOD TEST ABNORMAL 63 0.0045
342 BLOOD CALCIUM INCREASED 39 0.0044
343 EAR INFECTION 118 0.0044
344 HIP SURGERY 24 0.0044
345 ABNORMAL BEHAVIOUR 173 0.0044
346 INJECTION SITE HAEMATOMA 63 0.0043
347 HYPOGLYCAEMIA 209 0.0043
348 PETIT MAL EPILEPSY 22 0.0043
349 HEPATIC NEOPLASM 14 0.0043
350 DRUG DISPENSING ERROR 65 0.0042
351 GASTROINTESTINAL INFECTION 38 0.0042
352 PRESCRIBED OVERDOSE 82 0.0042
353 CEREBRAL DISORDER 31 0.0042
354 PHARMACEUTICAL PRODUCT COMPLAINT 108 0.0042
355 METABOLIC DISORDER 24 0.0041
356 SUSPECTED COUNTERFEIT PRODUCT 16 0.0040
357 MENINGITIS 27 0.0040
358 LEUKAEMIA 38 0.0040
359 LOWER LIMB FRACTURE 77 0.0040
360 IMPULSIVE BEHAVIOUR 15 0.0040
361 EOSINOPHIL COUNT INCREASED 33 0.0040
362 WEIGHT FLUCTUATION 41 0.0039
363 THERAPY INTERRUPTED 280 0.0039
364 OVERWEIGHT 21 0.0039
365 HEPATIC CIRRHOSIS 73 0.0039
366 PRODUCT DISTRIBUTION ISSUE 36 0.0039
367 THERAPY CESSATION 198 0.0039
368 DRUG PRESCRIBING ERROR 74 0.0038
369 SEIZURE 444 0.0038
370 AFFECTIVE DISORDER 30 0.0038
371 PHARYNGITIS STREPTOCOCCAL 41 0.0038
372 KIDNEY TRANSPLANT REJECTION 18 0.0037
373 LEFT VENTRICULAR HYPERTROPHY 16 0.0037
374 BRONCHIOLITIS 13 0.0037
375 VARICOSE VEIN 19 0.0037
376 HYPOTHYROIDISM 117 0.0037
377 AGGRESSION 182 0.0036
378 LIGAMENT RUPTURE 16 0.0036
379 THYROID FUNCTION TEST ABNORMAL 15 0.0036
380 RHINOVIRUS INFECTION 14 0.0036
381 INCORRECT PRODUCT STORAGE 47 0.0036
382 HEADACHE 2239 0.0036
383 SCRATCH 37 0.0035
384 WRIST FRACTURE 42 0.0035
385 JOINT DISLOCATION 37 0.0035
386 BLOOD SODIUM DECREASED 65 0.0034
387 TENSION 21 0.0034
388 INJECTION SITE INFLAMMATION 17 0.0034
389 BONE DISORDER 62 0.0034
390 PRODUCT PRESCRIBING ISSUE 74 0.0034
391 EATING DISORDER 72 0.0034
392 SPINAL DISORDER 32 0.0034
393 INTENTIONAL PRODUCT MISUSE 294 0.0034
394 LIMB OPERATION 16 0.0033
395 BRAIN OEDEMA 42 0.0033
396 MEDICATION ERROR 183 0.0033
397 INGUINAL HERNIA 20 0.0033
398 PARTIAL SEIZURES 17 0.0032
399 HYPERSOMNIA 93 0.0032
400 UMBILICAL HERNIA 15 0.0032
401 BLOOD GLUCOSE DECREASED 153 0.0032
402 FOOT DEFORMITY 35 0.0032
403 BLOOD GLUCOSE ABNORMAL 58 0.0031
404 PSYCHOMOTOR HYPERACTIVITY 52 0.0031
405 DRUG DELIVERY SYSTEM MALFUNCTION 16 0.0031
406 PRODUCT DOSE OMISSION IN ERROR 88 0.0031
407 MUSCLE DISORDER 25 0.0031
408 MALIGNANT MELANOMA 41 0.0031
409 COELIAC DISEASE 30 0.0031
410 PRODUCT PACKAGING ISSUE 29 0.0030
411 ANGIOPATHY 17 0.0030
412 WEIGHT INCREASED 673 0.0030
413 ANGER 101 0.0030
414 CYST 37 0.0030
415 BREAST MASS 20 0.0030
416 PRODUCT DELIVERY MECHANISM ISSUE 16 0.0030
417 HYPERTHYROIDISM 43 0.0030
418 JAW DISORDER 16 0.0029
419 THERAPEUTIC RESPONSE UNEXPECTED 131 0.0029
420 EXPIRED PRODUCT ADMINISTERED 97 0.0029
421 THIRST 52 0.0029
422 ANKLE FRACTURE 45 0.0029
423 BREAST PAIN 31 0.0029
424 INJECTION SITE RASH 88 0.0029
425 APPETITE DISORDER 19 0.0029
426 MASS 40 0.0029
427 CONTUSION 275 0.0029
428 FLUID RETENTION 145 0.0028
429 LIGAMENT SPRAIN 28 0.0028
430 OSTEONECROSIS 93 0.0028
431 DISEASE RECURRENCE 132 0.0028
432 NEOPLASM PROGRESSION 96 0.0028
433 SUDDEN DEATH 29 0.0027
434 HEPATOTOXICITY 61 0.0027
435 BODY HEIGHT DECREASED 29 0.0027
436 STREPTOCOCCAL INFECTION 15 0.0027
437 IMMUNE SYSTEM DISORDER 35 0.0027
438 HEPATOMEGALY 26 0.0026
439 DRUG EFFECT LESS THAN EXPECTED 39 0.0026
440 INITIAL INSOMNIA 27 0.0026
441 VISUAL FIELD DEFECT 19 0.0026
442 EMOTIONAL DISORDER 81 0.0026
443 IRRITABILITY 157 0.0026
444 STRESS FRACTURE 14 0.0026
445 PIGMENTATION DISORDER 16 0.0026
446 PRODUCT FORMULATION ISSUE 17 0.0026
447 MEDICAL DEVICE COMPLICATION 19 0.0026
448 BLOOD UREA INCREASED 43 0.0026
449 POLYURIA 21 0.0026
450 CARDIAC OPERATION 22 0.0026
451 DEAFNESS UNILATERAL 14 0.0025
452 PROSTATIC DISORDER 14 0.0025
453 CONVULSION 145 0.0025
454 MUSCLE ATROPHY 32 0.0025
455 BLOOD CHOLESTEROL INCREASED 117 0.0025
456 ELECTROLYTE IMBALANCE 29 0.0025
457 INJECTION SITE SWELLING 190 0.0025
458 PERIORBITAL SWELLING 14 0.0025
459 PERSONALITY CHANGE 23 0.0025
460 FOOD ALLERGY 19 0.0025
461 MALAISE 1078 0.0025
462 SUBARACHNOID HAEMORRHAGE 25 0.0025
463 MYOSITIS 22 0.0024
464 FRACTURE 46 0.0024
465 FOOT FRACTURE 46 0.0024
466 PALLOR 66 0.0024
467 INFLUENZA 269 0.0024
468 RESPIRATORY SYNCYTIAL VIRUS INFECTION 21 0.0024
469 NERVOUSNESS 126 0.0024
470 ATRIOVENTRICULAR BLOCK COMPLETE 16 0.0024
471 ILLNESS 246 0.0024
472 MIGRAINE 227 0.0024
473 BLOOD DISORDER 19 0.0024
474 HUNGER 33 0.0024
475 WRONG PRODUCT ADMINISTERED 16 0.0024
476 LIMB INJURY 64 0.0024
477 OFF LABEL USE 2049 0.0023
478 OBSTRUCTIVE AIRWAYS DISORDER 26 0.0023
479 BLINDNESS 95 0.0023
480 LYMPHOMA 36 0.0023
481 INJECTION SITE URTICARIA 57 0.0023
482 PAIN IN EXTREMITY 683 0.0023
483 BLOOD CALCIUM DECREASED 26 0.0023
484 LETHARGY 133 0.0023
485 HEAD INJURY 73 0.0023
486 ARTHRALGIA 959 0.0023
487 MOOD SWINGS 73 0.0023
488 BONE PAIN 134 0.0023
489 GLOMERULAR FILTRATION RATE DECREASED 28 0.0023
490 GROIN PAIN 20 0.0023
491 NEUTROPHIL COUNT INCREASED 23 0.0022
492 THYROID CANCER 27 0.0022
493 PRODUCT QUALITY ISSUE 303 0.0022
494 FRUSTRATION TOLERANCE DECREASED 18 0.0022
495 VISUAL ACUITY REDUCED 74 0.0022
496 ROAD TRAFFIC ACCIDENT 93 0.0022
497 SKIN LACERATION 24 0.0022
498 PYREXIA 763 0.0022
499 OVARIAN CYST 22 0.0022
500 BLOOD GLUCOSE INCREASED 413 0.0022
501 HAEMATOCRIT DECREASED 43 0.0022
502 BLOOD POTASSIUM DECREASED 65 0.0022
503 MENTAL DISORDER 94 0.0022
504 ARTHROPATHY 120 0.0022
505 SLUGGISHNESS 22 0.0022
506 PLATELET COUNT INCREASED 28 0.0021
507 BLOOD ALBUMIN DECREASED 17 0.0021
508 DRUG-INDUCED LIVER INJURY 67 0.0021
509 LABORATORY TEST ABNORMAL 63 0.0021
510 PRODUCT USE IN UNAPPROVED INDICATION 528 0.0021
511 OBSESSIVE-COMPULSIVE DISORDER 17 0.0021
512 INABILITY TO AFFORD MEDICATION 21 0.0021
513 DIABETES MELLITUS 161 0.0021
514 DEVELOPMENTAL DELAY 19 0.0021
515 EYE DISORDER 69 0.0021
516 INJECTION SITE NODULE 23 0.0021
517 POST PROCEDURAL COMPLICATION 40 0.0021
518 EXOSTOSIS 19 0.0021
519 SYNCOPE 207 0.0021
520 HOSPITALISATION 311 0.0020
521 JOINT INJURY 43 0.0020
522 INJECTION SITE INDURATION 26 0.0020
523 HYPOTONIA 20 0.0020
524 EYE SWELLING 74 0.0020
525 SURGERY 116 0.0020
526 RENAL DISORDER 91 0.0020
527 BLOOD IRON DECREASED 23 0.0019
528 TEMPERATURE INTOLERANCE 20 0.0019
529 INJECTION SITE REACTION 133 0.0019
530 KNEE OPERATION 19 0.0019
531 SLEEP DISORDER 136 0.0019
532 BONE DENSITY DECREASED 60 0.0019
533 LOWER RESPIRATORY TRACT INFECTION 87 0.0019
534 NEOPLASM MALIGNANT 127 0.0019
535 PERIPHERAL SWELLING 293 0.0019
536 RESPIRATORY TRACT INFECTION 49 0.0019
537 COLON CANCER 28 0.0019
538 NASOPHARYNGITIS 346 0.0019
539 TENDON RUPTURE 23 0.0019
540 POOR QUALITY SLEEP 40 0.0019
541 MEMORY IMPAIRMENT 255 0.0019
542 EXTRA DOSE ADMINISTERED 75 0.0018
543 AORTIC ANEURYSM 14 0.0018
544 INTERCEPTED PRODUCT ADMINISTRATION ERROR 14 0.0018
545 BLOOD GLUCOSE FLUCTUATION 20 0.0018
546 PULMONARY HYPERTENSION 38 0.0018
547 INTENTIONAL PRODUCT USE ISSUE 159 0.0018
548 TYPE 2 DIABETES MELLITUS 61 0.0018
549 HYPERGLYCAEMIA 66 0.0018
550 TREATMENT NONCOMPLIANCE 99 0.0018
551 SWELLING FACE 117 0.0018
552 BURNING SENSATION 126 0.0018
553 BASAL CELL CARCINOMA 28 0.0018
554 DRUG ADMINISTRATION ERROR 55 0.0018
555 INJECTION SITE ERYTHEMA 222 0.0018
556 SPINAL OPERATION 22 0.0018
557 BACK DISORDER 29 0.0018
558 OSTEOPENIA 27 0.0018
559 ARTHROPOD BITE 13 0.0018
560 NECK PAIN 98 0.0018
561 DIZZINESS POSTURAL 17 0.0018
562 WEIGHT DECREASED 489 0.0017
563 DEPRESSED MOOD 92 0.0017
564 RHINITIS 14 0.0017
565 NERVE COMPRESSION 16 0.0017
566 GRAND MAL CONVULSION 16 0.0017
567 PYELONEPHRITIS 15 0.0017
568 NOCTURIA 21 0.0017
569 DEAFNESS 45 0.0017
570 TRANSIENT ISCHAEMIC ATTACK 58 0.0017
571 HYPOACUSIS 74 0.0017
572 VISUAL IMPAIRMENT 213 0.0017
573 OEDEMA 93 0.0017
574 ALANINE AMINOTRANSFERASE INCREASED 105 0.0017
575 HYPERTHERMIA 13 0.0017
576 EAR PAIN 33 0.0017
577 DIABETES MELLITUS INADEQUATE CONTROL 30 0.0017
578 MUSCULOSKELETAL DISCOMFORT 29 0.0017
579 FEMUR FRACTURE 52 0.0017
580 SKIN DISORDER 56 0.0017
581 RECALLED PRODUCT ADMINISTERED 16 0.0017
582 JOINT STIFFNESS 44 0.0017
583 VOMITING 787 0.0017
584 FATIGUE 1299 0.0017
585 NERVOUS SYSTEM DISORDER 52 0.0017
586 FACE OEDEMA 28 0.0017
587 LYMPHOCYTE COUNT DECREASED 29 0.0016
588 FEELING ABNORMAL 393 0.0016
589 NEPHROLITHIASIS 75 0.0016
590 DRUG EFFECT INCOMPLETE 59 0.0016
591 CARDIOMYOPATHY 24 0.0016
592 HYPERCALCAEMIA 20 0.0016
593 SKIN HAEMORRHAGE 24 0.0016
594 DISTURBANCE IN ATTENTION 87 0.0016
595 RESPIRATORY DISORDER 48 0.0016
596 ASPARTATE AMINOTRANSFERASE INCREASED 85 0.0016
597 BLOOD BILIRUBIN INCREASED 43 0.0016
598 PRODUCT COMPLAINT 40 0.0016
599 PROTEINURIA 30 0.0016
600 MUSCULOSKELETAL DISORDER 30 0.0016
601 STEVENS-JOHNSON SYNDROME 35 0.0016
602 INSURANCE ISSUE 24 0.0016
603 SOMNOLENCE 316 0.0016
604 COGNITIVE DISORDER 73 0.0016
605 IMMUNODEFICIENCY 23 0.0015
606 GENERALISED OEDEMA 19 0.0015
607 OSTEOPOROSIS 63 0.0015
608 PERIPHERAL COLDNESS 21 0.0015
609 KIDNEY INFECTION 30 0.0015
610 PRODUCT USE ISSUE 285 0.0015
611 GALLBLADDER DISORDER 27 0.0015
612 ASTHENIA 566 0.0015
613 RED BLOOD CELL COUNT DECREASED 43 0.0015
614 CARDIAC MURMUR 13 0.0015
615 HIP ARTHROPLASTY 23 0.0015
616 OEDEMA PERIPHERAL 183 0.0015
617 INJECTION SITE IRRITATION 19 0.0015
618 LOSS OF CONSCIOUSNESS 191 0.0015
619 HYPERSENSITIVITY 276 0.0015
620 INTRAOCULAR PRESSURE INCREASED 19 0.0015
621 SEASONAL ALLERGY 21 0.0015
622 INCORRECT ROUTE OF DRUG ADMINISTRATION 53 0.0015
623 INJECTION SITE PRURITUS 99 0.0015
624 LYMPHADENOPATHY 52 0.0015
625 DRUG ABUSE 122 0.0015
626 COVID-19 257 0.0015
627 ACNE 111 0.0015
628 APPLICATION SITE PAIN 32 0.0015
629 SPLENOMEGALY 17 0.0014
630 PHARYNGITIS 18 0.0014
631 DRUG LEVEL INCREASED 24 0.0014
632 APATHY 21 0.0014
633 AUTOIMMUNE DISORDER 14 0.0014
634 INTENTIONAL SELF-INJURY 29 0.0014
635 MALNUTRITION 16 0.0014
636 ANXIETY 407 0.0014
637 DISCOMFORT 87 0.0014
638 HYPERLIPIDAEMIA 17 0.0014
639 GYNAECOMASTIA 44 0.0014
640 CARDIAC DISORDER 133 0.0014
641 INSOMNIA 378 0.0014
642 INTERVERTEBRAL DISC PROTRUSION 31 0.0014
643 BLOOD POTASSIUM INCREASED 23 0.0014
644 CIRCULATORY COLLAPSE 24 0.0014
645 CHOLELITHIASIS 46 0.0014
646 BRONCHOSPASM 20 0.0014
647 PARALYSIS 20 0.0014
648 CEREBROVASCULAR ACCIDENT 236 0.0014
649 OROPHARYNGEAL PAIN 128 0.0014
650 CARDIOMEGALY 17 0.0014
651 RHINORRHOEA 89 0.0014
652 DRUG LEVEL DECREASED 14 0.0014
653 DIABETIC KETOACIDOSIS 33 0.0014
654 VASCULITIS 16 0.0014
655 SKIN DISCOLOURATION 63 0.0014
656 BLOOD URINE PRESENT 26 0.0014
657 CONDITION AGGRAVATED 416 0.0014
658 DEVICE RELATED INFECTION 21 0.0014
659 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 97 0.0014
660 MYALGIA 231 0.0014
661 HEMIPARESIS 23 0.0014
662 HEAD DISCOMFORT 24 0.0014
663 ABDOMINAL PAIN UPPER 277 0.0013
664 HERNIA 26 0.0013
665 MIDDLE INSOMNIA 25 0.0013
666 EPISTAXIS 100 0.0013
667 OCULAR DISCOMFORT 15 0.0013
668 STAPHYLOCOCCAL INFECTION 44 0.0013
669 SINUSITIS 136 0.0013
670 OSTEOARTHRITIS 56 0.0013
671 UNRESPONSIVE TO STIMULI 34 0.0013
672 FEELING HOT 80 0.0013
673 HYPERHIDROSIS 168 0.0013
674 GASTRIC HAEMORRHAGE 15 0.0013
675 ABORTION SPONTANEOUS 52 0.0013
676 SWELLING 121 0.0013
677 TENDONITIS 20 0.0013
678 CEREBRAL HAEMORRHAGE 46 0.0013
679 HYPOTHERMIA 13 0.0013
680 MENTAL IMPAIRMENT 31 0.0013
681 BRAIN FOG 20 0.0013
682 SKIN LESION 35 0.0013
683 PRESYNCOPE 31 0.0013
684 BODY TEMPERATURE INCREASED 26 0.0013
685 POLLAKIURIA 53 0.0013
686 FALL 422 0.0013
687 DEPRESSION 288 0.0013
688 PAIN 777 0.0013
689 HYPONATRAEMIA 71 0.0013
690 GASTRITIS 33 0.0013
691 DEMENTIA 35 0.0013
692 HYPOPHAGIA 32 0.0013
693 ACCIDENTAL UNDERDOSE 18 0.0012
694 CONJUNCTIVITIS 23 0.0012
695 PNEUMONIA 401 0.0012
696 HEPATIC STEATOSIS 23 0.0012
697 ISCHAEMIC STROKE 22 0.0012
698 DIPLOPIA 32 0.0012
699 URTICARIA 206 0.0012
700 LIMB DISCOMFORT 38 0.0012
701 ACUTE MYELOID LEUKAEMIA 19 0.0012
702 DEHYDRATION 162 0.0012
703 AMNESIA 79 0.0012
704 BACK PAIN 282 0.0012
705 BLINDNESS UNILATERAL 17 0.0012
706 ASTHMA 136 0.0012
707 JOINT SWELLING 145 0.0012
708 BIPOLAR DISORDER 13 0.0012
709 AGITATION 87 0.0012
710 INFECTION 171 0.0012
711 MUSCLE TIGHTNESS 19 0.0012
712 DECREASED APPETITE 272 0.0012
713 PHOTOPHOBIA 22 0.0012
714 OVERDOSE 252 0.0012
715 ROTATOR CUFF SYNDROME 15 0.0012
716 HEART RATE INCREASED 115 0.0012
717 CORONARY ARTERY DISEASE 35 0.0012
718 INCORRECT PRODUCT ADMINISTRATION DURATION 25 0.0012
719 NO THERAPEUTIC RESPONSE 14 0.0011
720 CATARACT 68 0.0011
721 ABDOMINAL PAIN 265 0.0011
722 PNEUMOTHORAX 18 0.0011
723 EYE HAEMORRHAGE 15 0.0011
724 PALPITATIONS 131 0.0011
725 EYELID OEDEMA 13 0.0011
726 RIB FRACTURE 23 0.0011
727 PANCREATITIS ACUTE 25 0.0011
728 SCAR 19 0.0011
729 GAIT DISTURBANCE 212 0.0011
730 GASTRIC DISORDER 38 0.0011
731 GAIT INABILITY 37 0.0011
732 SPEECH DISORDER 58 0.0011
733 HYPERTENSION 234 0.0011
734 CARDIOVASCULAR DISORDER 28 0.0011
735 IMPAIRED GASTRIC EMPTYING 15 0.0011
736 HIP FRACTURE 35 0.0011
737 GENERALISED TONIC-CLONIC SEIZURE 18 0.0011
738 UPPER RESPIRATORY TRACT INFECTION 50 0.0011
739 CYANOSIS 17 0.0011
740 HAEMATOMA 28 0.0011
741 URINARY INCONTINENCE 32 0.0011
742 FEELING COLD 30 0.0011
743 THROAT TIGHTNESS 29 0.0011
744 HAEMORRHAGE 112 0.0011
745 HAEMORRHAGE INTRACRANIAL 16 0.0011
746 SKIN REACTION 15 0.0011
747 SARS-COV-2 TEST POSITIVE 14 0.0011
748 DIZZINESS 528 0.0011
749 VISION BLURRED 145 0.0011
750 BRONCHITIS 78 0.0011
751 OSTEOMYELITIS 19 0.0010
752 KNEE ARTHROPLASTY 22 0.0010
753 QUALITY OF LIFE DECREASED 14 0.0010
754 RASH GENERALISED 27 0.0010
755 ARTHRITIS 82 0.0010
756 HYPOAESTHESIA 156 0.0010
757 NASAL CONGESTION 61 0.0010
758 INFLUENZA LIKE ILLNESS 85 0.0010
759 MUSCULOSKELETAL PAIN 54 0.0010
760 TREMOR 171 0.0010
761 FIBROMYALGIA 25 0.0010
762 EYE PAIN 58 0.0010
763 DEATH 874 0.0010
764 OXYGEN SATURATION DECREASED 57 0.0010
765 PERITONITIS 21 0.0010
766 SINUS DISORDER 20 0.0010
767 TACHYCARDIA 89 0.0010
768 TINNITUS 46 0.0010
769 GASTROINTESTINAL DISORDER 89 0.0010
770 TRANSAMINASES INCREASED 22 0.0010
771 DIALYSIS 14 0.0010
772 GLAUCOMA 19 0.0010
773 DIVERTICULITIS 27 0.0010
774 HAIR TEXTURE ABNORMAL 13 0.0010
775 FAECES DISCOLOURED 21 0.0010
776 VERTIGO 59 0.0010
777 FEAR 26 0.0010
778 NO ADVERSE EVENT 174 0.0010
779 PROSTATE CANCER 76 0.0009
780 ANGINA PECTORIS 27 0.0009
781 MUSCULAR WEAKNESS 107 0.0009
782 ABSCESS 15 0.0009
783 SNEEZING 21 0.0009
784 DEPRESSED LEVEL OF CONSCIOUSNESS 37 0.0009
785 RHABDOMYOLYSIS 39 0.0009
786 SENSORY DISTURBANCE 15 0.0009
787 IRRITABLE BOWEL SYNDROME 20 0.0009
788 MOBILITY DECREASED 67 0.0009
789 ECONOMIC PROBLEM 14 0.0009
790 COUGH 259 0.0009
791 PNEUMONIA ASPIRATION 23 0.0009
792 CHEST PAIN 170 0.0009
793 PSYCHOTIC DISORDER 27 0.0009
794 RESPIRATORY DISTRESS 25 0.0009
795 NIGHT SWEATS 29 0.0009
796 HEPATITIS 23 0.0009
797 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 43 0.0009
798 INFLAMMATION 46 0.0009
799 MUSCULOSKELETAL STIFFNESS 78 0.0009
800 CONSTIPATION 194 0.0009
801 ILL-DEFINED DISORDER 54 0.0009
802 BLOOD CREATININE INCREASED 58 0.0009
803 WITHDRAWAL SYNDROME 37 0.0009
804 PRURITUS GENERALISED 19 0.0009
805 ABDOMINAL DISTENSION 91 0.0009
806 RESPIRATORY ARREST 24 0.0009
807 CHRONIC KIDNEY DISEASE 66 0.0009
808 BLOOD CREATINE PHOSPHOKINASE INCREASED 25 0.0009
809 RASH 378 0.0009
810 DRUG INEFFECTIVE 1137 0.0009
811 SEPSIS 96 0.0009
812 ERECTILE DYSFUNCTION 22 0.0009
813 BLOOD PRESSURE ABNORMAL 17 0.0009
814 TOOTH DISORDER 19 0.0009
815 PARAESTHESIA 134 0.0009
816 INJURY 59 0.0008
817 URINARY TRACT INFECTION 142 0.0008
818 LOCALISED INFECTION 20 0.0008
819 SHOCK 19 0.0008
820 MUSCLE TWITCHING 19 0.0008
821 PANIC ATTACK 30 0.0008
822 IMPAIRED HEALING 27 0.0008
823 DYSPHONIA 48 0.0008
824 PRODUCT SUBSTITUTION ISSUE 47 0.0008
825 ACUTE MYOCARDIAL INFARCTION 24 0.0008
826 GENERAL PHYSICAL HEALTH DETERIORATION 94 0.0008
827 MULTI-ORGAN FAILURE 14 0.0008
828 NIGHTMARE 28 0.0008
829 BACTERIAL INFECTION 15 0.0008
830 RASH PAPULAR 18 0.0008
831 SUICIDAL IDEATION 73 0.0008
832 NAUSEA 630 0.0008
833 PANCREATITIS 42 0.0008
834 CELLULITIS 40 0.0008
835 FEEDING DISORDER 16 0.0008
836 COAGULOPATHY 13 0.0008
837 CONFUSIONAL STATE 126 0.0008
838 CEREBRAL INFARCTION 19 0.0008
839 COMA 37 0.0008
840 DRUG INTERACTION 123 0.0008
841 ABDOMINAL DISCOMFORT 130 0.0008
842 ALOPECIA 152 0.0008
843 MUSCLE SPASMS 142 0.0008
844 HAEMOGLOBIN DECREASED 79 0.0008
845 RENAL FAILURE 101 0.0008
846 ARRHYTHMIA 36 0.0008
847 HAEMATURIA 26 0.0008
848 BLOOD PRESSURE INCREASED 116 0.0008
849 HOT FLUSH 57 0.0008
850 BLISTER 42 0.0007
851 SKIN CANCER 16 0.0007
852 NEURALGIA 18 0.0007
853 BLOOD PRESSURE DECREASED 49 0.0007
854 LUNG DISORDER 36 0.0007
855 THROMBOSIS 59 0.0007
856 ENCEPHALOPATHY 18 0.0007
857 PULMONARY FIBROSIS 14 0.0007
858 LACRIMATION INCREASED 22 0.0007
859 URINARY RETENTION 24 0.0007
860 WRONG TECHNIQUE IN DRUG USAGE PROCESS 26 0.0007
861 END STAGE RENAL DISEASE 13 0.0007
862 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 128 0.0007
863 DISABILITY 14 0.0007
864 WHITE BLOOD CELL COUNT INCREASED 27 0.0007
865 RETCHING 15 0.0007
866 DRY SKIN 93 0.0007
867 ABASIA 17 0.0007
868 CARDIAC FAILURE 55 0.0007
869 DYSSTASIA 20 0.0007
870 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 20 0.0007
871 RENAL IMPAIRMENT 57 0.0007
872 TOOTH LOSS 14 0.0007
873 HEPATIC ENZYME INCREASED 46 0.0007
874 HAEMATEMESIS 17 0.0007
875 THERAPEUTIC PRODUCT EFFECT DECREASED 30 0.0007
876 CHOKING 13 0.0007
877 INTESTINAL OBSTRUCTION 25 0.0007
878 ANAPHYLACTIC SHOCK 17 0.0007
879 DISORIENTATION 26 0.0007
880 ANHEDONIA 17 0.0006
881 DYSARTHRIA 24 0.0006
882 MYOCARDIAL INFARCTION 111 0.0006
883 FLATULENCE 36 0.0006
884 UNEVALUABLE EVENT 48 0.0006
885 ANAEMIA 121 0.0006
886 BREAST CANCER 59 0.0006
887 DRUG INTOLERANCE 61 0.0006
888 LIP SWELLING 21 0.0006
889 CYSTITIS 20 0.0006
890 METABOLIC ACIDOSIS 20 0.0006
891 DYSURIA 23 0.0006
892 HYPOXIA 22 0.0006
893 MATERNAL EXPOSURE DURING PREGNANCY 55 0.0006
894 DIARRHOEA 398 0.0006
895 LIVER DISORDER 27 0.0006
896 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 33 0.0006
897 MENSTRUATION IRREGULAR 16 0.0006
898 CARDIAC ARREST 49 0.0006
899 ECZEMA 31 0.0006
900 SYSTEMIC LUPUS ERYTHEMATOSUS 21 0.0006
901 HAEMATOCHEZIA 32 0.0006
902 C-REACTIVE PROTEIN INCREASED 21 0.0006
903 RESPIRATORY FAILURE 42 0.0006
904 HEART RATE IRREGULAR 13 0.0006
905 CARDIO-RESPIRATORY ARREST 24 0.0006
906 RESTLESSNESS 21 0.0006
907 RASH MACULAR 20 0.0006
908 RASH PRURITIC 31 0.0006
909 GASTROOESOPHAGEAL REFLUX DISEASE 46 0.0006
910 DISEASE PROGRESSION 67 0.0006
911 DYSKINESIA 23 0.0006
912 ANGIOEDEMA 25 0.0006
913 NEUTROPHIL COUNT DECREASED 23 0.0006
914 AGEUSIA 14 0.0006
915 MOVEMENT DISORDER 18 0.0006
916 COLITIS ULCERATIVE 25 0.0006
917 THERAPY NON-RESPONDER 25 0.0006
918 DYSPNOEA 309 0.0005
919 ANAPHYLACTIC REACTION 30 0.0005
920 WHITE BLOOD CELL COUNT DECREASED 58 0.0005
921 CONTRAINDICATED PRODUCT ADMINISTERED 16 0.0005
922 COLITIS 20 0.0005
923 ADVERSE DRUG REACTION 47 0.0005
924 CHILLS 60 0.0005
925 THERAPEUTIC RESPONSE DECREASED 31 0.0005
926 BALANCE DISORDER 44 0.0005
927 WHEEZING 30 0.0005
928 ADVERSE EVENT 46 0.0005
929 CHEST DISCOMFORT 50 0.0005
930 LUNG NEOPLASM MALIGNANT 20 0.0005
931 LIVER FUNCTION TEST ABNORMAL 14 0.0005
932 HYPOKALAEMIA 22 0.0005
933 PULMONARY EMBOLISM 45 0.0005
934 ERYTHEMA 97 0.0005
935 DYSGEUSIA 35 0.0005
936 DRUG WITHDRAWAL SYNDROME 41 0.0005
937 HALLUCINATION 35 0.0005
938 SUICIDE ATTEMPT 28 0.0005
939 PRODUCTIVE COUGH 22 0.0005
940 RASH ERYTHEMATOUS 22 0.0005
941 PLEURAL EFFUSION 28 0.0005
942 SEPTIC SHOCK 20 0.0005
943 HEART RATE DECREASED 16 0.0005
944 HYPOTENSION 91 0.0005
945 PULMONARY OEDEMA 20 0.0004
946 OCULAR HYPERAEMIA 21 0.0004
947 RECTAL HAEMORRHAGE 19 0.0004
948 PLATELET COUNT DECREASED 47 0.0004
949 PRURITUS 168 0.0004
950 DEVICE DISLOCATION 19 0.0004
951 ATRIAL FIBRILLATION 42 0.0004
952 CARDIAC FAILURE CONGESTIVE 34 0.0004
953 DYSPHAGIA 40 0.0004
954 DRY MOUTH 34 0.0004
955 BRADYCARDIA 21 0.0004
956 EMOTIONAL DISTRESS 47 0.0004
957 NEUROPATHY PERIPHERAL 36 0.0004
958 MULTIPLE SCLEROSIS 18 0.0004
959 THROMBOCYTOPENIA 42 0.0004
960 HEPATIC FUNCTION ABNORMAL 14 0.0004
961 DRUG EFFECT DECREASED 20 0.0004
962 ACUTE KIDNEY INJURY 56 0.0004
963 HERPES ZOSTER 21 0.0004
964 DERMATITIS ATOPIC 19 0.0004
965 THROAT IRRITATION 16 0.0004
966 FLUSHING 36 0.0004
967 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 25 0.0004
968 DYSPEPSIA 34 0.0003
969 LEUKOPENIA 17 0.0003
970 RENAL FAILURE ACUTE 14 0.0003
971 SKIN EXFOLIATION 26 0.0003
972 STOMATITIS 18 0.0003
973 EYE IRRITATION 17 0.0003
974 GASTROINTESTINAL HAEMORRHAGE 24 0.0003
975 BLADDER CANCER 15 0.0003
976 INTENTIONAL OVERDOSE 16 0.0002
977 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13 0.0002
978 FOETAL EXPOSURE DURING PREGNANCY 20 0.0002
979 EXPOSURE DURING PREGNANCY 15 0.0002
980 NEUTROPENIA 32 0.0002
981 DEEP VEIN THROMBOSIS 15 0.0002
982 RHEUMATOID ARTHRITIS 21 0.0002
983 TREATMENT FAILURE 14 0.0002
984 PSORIASIS 18 0.0001
985 DRUG DEPENDENCE 21 0.0001